Brie Chun

Multiplex immunofluorescence to measure dynamic changes in tumor-infiltrating lymphocytes and PD-L1 in early-stage breast cancer

Katherine Sanchez, Isaac Kim, Brie Chun et al. · Breast Cancer Research · 2021 · 66 citations · Full text

Secretory clusterin (sCLU) overexpression is associated with resistance to preoperative neoadjuvant chemotherapy in primary breast cancer.

Niu Zh, Y Wang, Brie Chun et al. · PubMed · 2013 · 30 citations

A Case Series of Metastatic Metaplastic Breast Carcinoma Treated With Anti-PD-1 Therapy

Isaac Kim, Venkatesh Rajamanickam, Brady Bernard et al. · Frontiers in Oncology · 2021 · 29 citations · Full text

Breast Oncology, Anti-pd-1 Therapy, Pd-l1 Expression +13

Pembrolizumab (pembro) with paclitaxel (taxol) or capecitabine (cape) as early treatment of metastatic triple-negative breast cancer (mTNBC).

David B. Page, Brie Chun, Joanna Pucilowska et al. · Journal of Clinical Oncology · 2019 · 19 citations

Breast Oncology, Pharmacotherapy, Taxol Orr +19

Changes in T-cell subsets and clonal repertoire during chemoimmunotherapy with pembrolizumab and paclitaxel or capecitabine for metastatic triple-negative breast cancer

Brie Chun, Joanna Pucilowska, Shu‐Ching Chang et al. · Journal for ImmunoTherapy of Cancer · 2022 · 17 citations · Full text